You have read all your free articles, to continue reading subscribe to read the rest of this content.
A new AI solution for sustainable production is to be tested at Diamyd Medical’s vaccine manufacturing facility in Umeå. It is hoped, once the solution has been refined, that it can be introduced in companies throughout Sweden. “This represents a unique opportunity that we do not see thatAlready a subscriber…
Pharmaceutical company MSD is moving to the new Stockholm life science cluster. The company has been located in Sollentuna, outside of Stockholm, for the last 25 years but will change locations to Hagastaden during the spring of 2015. "For MSD in Sweden it is important to be part of the…
The Board of Directors of Xbrane Biopharma has successfully completed a directed issue of 3,853,799 shares corresponding to approximately SEK 146 million before costs related to the transaction. The subscription price in the Directed Share Issue has been determined to 38 SEK per share through an Already a subscriber Login…
Sprint Bioscience is broadening its pipeline with an additional drug program for the treatment of solid tumors. The program goes by the program name NIMA and aims to develop drugs to inhibit a naturally occurring protein that is associated with poor survival in several different forms of cancer, Already a…
